Stockreport

Eagle Pharmaceuticals Announces a Trial in Progress Presentation of Phase 2/3 Study of Intravenous Amisulpride as Prevention of Postoperative Nausea and Vomiting in Pediatric Patients at t...

Eagle Pharmaceuticals, Inc.  (EGRX) 
Last eagle pharmaceuticals, inc. earnings: 3/2 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: investor.eagleus.com
PDF WOODCLIFF LAKE, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that it will deliver a T [Read more]